In reinstating human ADME to its portfolio, SGS strengths its ability to support drug development programmes with critical early clinical data. FANC approval enables SGS to reintroduce ¹⁴C human ADME ...
Prognostic significance of day+14 plasma cell count after initial induction therapy in Acute Myeloid Leukemia. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results